The retaliatory measures followed Trump's controversial move to order the withdrawal of all U.S. troops from Syria's northern border with Turkey.Politicsread more
Bloomberg could be in for a showdown with Elizabeth Warren, whether he runs or not.2020 Electionsread more
As the season kicks into gear this week, S&P 500 firms are expected to report a 4.6% earnings decline over the same period a year agoEarningsread more
"I think that may have scared the Chinese that they were going to get into a serious trade war with access to our capital markets being cut off, among other things," Michael...China Politicsread more
David Rolfe, a longtime Berkshire Hathaway shareholder and CIO at Wedgewood Partners, is fed up with Warren Buffett.Marketsread more
Bank of America says investors should still look to stocks for value rather than bonds.Investingread more
Wall Street analysts estimate GM has lost more than $1 billion due to the United Auto Workers' strike, which began Sept. 16.Autosread more
Top financial companies will mark the unofficial start of earnings season with their reports this week, and experts are offering several recommendations for trading the moves.ETF Edgeread more
The indexes traded in a tight range as investors looked ahead to the start of the earnings season while grappling with new worries over trade.Marketsread more
The union that represents Southwest Airlines pilots don't expect the grounded Boeing 737 Max to return until at least February, about a month later than the airline expects.Airlinesread more
Check out the companies making headlines in midday trading:Market Insiderread more
further notice@ (Corrects "until February" to "until further notice" in headline and "new court date" to "court status conference" in paragraphs 1 & 6)
FRANKFURT, Oct 6 (Reuters) - A pending U.S. lawsuit over claims related to Bayer's glyphosate-based herbicide Roundup has been delayed, the company said on Sunday, with a court status conference in February, 2020.
"The Oct. 15, 2019 trial date for Winston v. Monsanto in St. Louis City has been postponed," Bayer said in a statement.
The lawsuit is the latest of several to be delayed as mediator Ken Feinberg tries to negotiate a settlement between the company and U.S. plaintiffs after a California jury in August last year found that Monsanto should have warned of alleged cancer risks.
"With the change in the trial schedule and no trial dates set through the rest of the year, the appeals of the three completed trials will be a significant focus of the litigation in the months ahead," Bayer said.
Handelsblatt first reported the latest delay earlier on Sunday.
A court document from the Circuit Court of the City of St. Louis, dated October 4, said a status conference to reevaluate the case had been set for February 10.
The number of U.S. plaintiffs blaming Roundup and other glyphosate-based weed killers for cancer has been rising continuously to stand at 18,400 as of July 11, hitting Bayer's share price. (Reporting by Tina Bellon; Editing by Kirsten Donovan)